Skip to main content
Journal cover image

Transapical and Transaortic Transcatheter Aortic Valve Replacement in the United States.

Publication ,  Journal Article
Thourani, VH; Jensen, HA; Babaliaros, V; Suri, R; Vemulapalli, S; Dai, D; Brennan, JM; Rumsfeld, J; Edwards, F; Tuzcu, EM; Svensson, L ...
Published in: Ann Thorac Surg
November 2015

BACKGROUND: When transcatheter aortic valve replacement (TAVR) cannot be carried out through transfemoral access, alternative access TAVR is indicated. The purpose of this study was to explore inhospital and 1-year outcomes of patients undergoing alternative access TAVR through the transapical (TA) or transaortic (TAo) techniques in the United States. METHODS: Clinical records of 4,953 patients undergoing TA (n = 4,085) or TAo (n = 868) TAVR from 2011 to 2014 in The Society of Thoracic Surgeons (STS)/American College of Cardiology Transcatheter Valve Therapy Registry were linked to Centers for Medicare and Medicaid Services hospital claims. Inhospital and 1-year clinical outcomes were stratified by operative risk; and the risk-adjusted association between access route and mortality, stroke, and heart failure repeat hospitalization was explored. RESULTS: Mean age for all patients was 82.8 ± 6.8 years. The median STS predicted risk of mortality was significantly higher among patients undergoing TAo (8.8 versus 7.4, p < 0.001). When compared with TA, TAo was associated with an increased risk of unadjusted 30-day mortality (10.3% versus 8.8%) and 1-year mortality (30.3% versus 25.6%, p = 0.006). There were no significant differences between TAo and TA for inhospital stroke rate (2.2%), major vascular complications (0.3%), and 1-year heart failure rehospitalizations (15.7%). Examination of high-risk and inoperable subgroups showed that 1-year mortality was significantly higher for TAo patients classified as inoperable (p = 0.012). CONCLUSIONS: Patients undergoing TAo TAVR are older, more likely female, and have significantly higher STS predicted risk of mortality scores than patients operated on by TA access. There were no risk-adjusted differences between TA and TAo access in mortality, stroke, or readmission rates as long as 1 year after TAVR.

Duke Scholars

Published In

Ann Thorac Surg

DOI

EISSN

1552-6259

Publication Date

November 2015

Volume

100

Issue

5

Start / End Page

1718 / 1726

Location

Netherlands

Related Subject Headings

  • United States
  • Treatment Outcome
  • Transcatheter Aortic Valve Replacement
  • Survival Rate
  • Risk Factors
  • Risk Assessment
  • Respiratory System
  • Registries
  • Postoperative Complications
  • Male
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Thourani, V. H., Jensen, H. A., Babaliaros, V., Suri, R., Vemulapalli, S., Dai, D., … Mack, M. (2015). Transapical and Transaortic Transcatheter Aortic Valve Replacement in the United States. Ann Thorac Surg, 100(5), 1718–1726. https://doi.org/10.1016/j.athoracsur.2015.05.010
Thourani, Vinod H., Hanna A. Jensen, Vasilis Babaliaros, Rakesh Suri, Sreekanth Vemulapalli, David Dai, J Matthew Brennan, et al. “Transapical and Transaortic Transcatheter Aortic Valve Replacement in the United States.Ann Thorac Surg 100, no. 5 (November 2015): 1718–26. https://doi.org/10.1016/j.athoracsur.2015.05.010.
Thourani VH, Jensen HA, Babaliaros V, Suri R, Vemulapalli S, Dai D, et al. Transapical and Transaortic Transcatheter Aortic Valve Replacement in the United States. Ann Thorac Surg. 2015 Nov;100(5):1718–26.
Thourani, Vinod H., et al. “Transapical and Transaortic Transcatheter Aortic Valve Replacement in the United States.Ann Thorac Surg, vol. 100, no. 5, Nov. 2015, pp. 1718–26. Pubmed, doi:10.1016/j.athoracsur.2015.05.010.
Thourani VH, Jensen HA, Babaliaros V, Suri R, Vemulapalli S, Dai D, Brennan JM, Rumsfeld J, Edwards F, Tuzcu EM, Svensson L, Szeto WY, Herrmann H, Kirtane AJ, Kodali S, Cohen DJ, Lerakis S, Devireddy C, Sarin E, Carroll J, Holmes D, Grover FL, Williams M, Maniar H, Shahian D, Mack M. Transapical and Transaortic Transcatheter Aortic Valve Replacement in the United States. Ann Thorac Surg. 2015 Nov;100(5):1718–1726.
Journal cover image

Published In

Ann Thorac Surg

DOI

EISSN

1552-6259

Publication Date

November 2015

Volume

100

Issue

5

Start / End Page

1718 / 1726

Location

Netherlands

Related Subject Headings

  • United States
  • Treatment Outcome
  • Transcatheter Aortic Valve Replacement
  • Survival Rate
  • Risk Factors
  • Risk Assessment
  • Respiratory System
  • Registries
  • Postoperative Complications
  • Male